Real-World Costs of Laboratory Tests for Non-Small Cell Lung Cancer

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Real-World Data on Nivolumab Treatment of Non-Small Cell Lung Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2016English

Pcn210 - Using Real World Data to Determine Health System Costs of a 5-Year Non-Small Cell Lung Cancer Cohort

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

P1.01-01 ROS1-Positive Non-Small Cell Lung Cancer: Real-World Data in Korea

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Real World Treatment Patterns and Resource Use for Advanced Non-Small Cell Lung Cancer in Brazilian Private Institutions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Optimal Sequence of Tests for the Mediastinal Staging of Non-Small Cell Lung Cancer

BMC Medical Informatics and Decision Making
Health PolicyHealth Informatics
2016English

P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients With Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Real‐world Progression, Treatment, and Survival Outcomes During Rapid Adoption of Immunotherapy for Advanced Non–small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2019English

Non-Small Cell Lung Cancer

English

Pcn120 - Epidemiology and Costs of Non-Small Cell Lung Cancer (Nsclc) in Austria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy